Ribavirin for Chronic Hepatitis Prevention among Patients with Hematologic Malignancies

Tavitian, Suzanne; Peron, Jean-Marie; Huguet, Françoise; Kamar, Nassim; Abravanel, Florence; Beyne-Rauzy, Odile; Oberic, Lucie; Faguer, Stanislas; Alric, Laurent; Roussel, Murielle; Gaudin, Clément; Ysebaert, Loïc; Huynh, Anne; Recher, Christian

doi:10.3201/eid2108.150199

i

Ribavirin for Chronic Hepatitis Prevention among Patients with Hematologic Malignancies

Supporting Files Public Domain

Aug 2015
By Tavitian, Suzanne ; Peron, Jean-Marie ; Huguet, Françoise ; ...

Details

Alternative Title:

Emerg Infect Dis
Personal Author:

Tavitian, Suzanne ; Peron, Jean-Marie ; Huguet, Françoise ; Kamar, Nassim ; Abravanel, Florence ; Beyne-Rauzy, Odile ; Oberic, Lucie ; Faguer, Stanislas ; Alric, Laurent ; Roussel, Murielle ; Gaudin, Clément ; Ysebaert, Loïc ; Huynh, Anne ; Recher, Christian
Description:

Findings among a cohort of 26 patients who had hematologic malignancies and hepatitis E virus (HEV) infection support that HEV can induce chronic hepatitis. However, a 3-month course of ribavirin can induce a rapid viral clearance, reducing the risk for chronic hepatitis and enabling continuation of cytotoxic treatments for underlying malignancies.
Subjects:

Chronic Hepatitis Cirrhosis Dispatch Hematology Hepatitis E Malignancy Ribavirin Ribavirin For Chronic Hepatitis Prevention Among Patients With Hematologic Malignancies Viruses
Source:

Emerg Infect Dis. 21(8):1466-1469.
Pubmed ID:

26197210
Pubmed Central ID:

PMC4517705
Document Type:

Journal Article
Volume:

21
Issue:

8
Collection(s):

Emerging Infectious Diseases
Main Document Checksum:

urn:sha256:36692405f83e7d18ecf3059e02c56f53f4248f47943d3a5995f9ed79203a1f61
Download URL:

https://stacks.cdc.gov/view/cdc/32667/cdc_32667_DS1.pdf
File Type:

[PDF - 814.00 KB ]

ON THIS PAGE

Details Supporting Files

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.

As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.